InsideArbitrage Event Driven Monitor – April 7, 2026

Note: You can click on any section title to jump straight to the related tool or page. Merger Arbitrage SLNO: The acquisition of Soleno Therapeutics, Inc. (SLNO) by Neurocrine Biosciences, Inc. (NBIX) for a closing value of $2.9 billion. Neurocrine, through a subsidiary, will commence a cash tender offer to acquire all of the outstanding shares